Trial intelligence / Profile preview

ARISE: MFat vs Corticosteroid for Knee Osteoarthritis

NCT05660772Phase 3Completed

Sponsor
Lipogems
Start
Dec 2022
Primary completion
Apr 2025
Modality
Cell Therapies
Countries
1
01

Overview

A Phase 3 trial of microfragmented adipose tissue in osteoarthritis (OA), sponsored by Lipogems. Started Dec 2022; status: completed.

02

Drugs

microfragmented adipose tissue
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT05660772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05660772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call